Clinical Trial Details
| Trial ID: | L0100 |
| Source ID: | NCT00389376 |
| Associated Drug: | Silymarin |
| Title: | Phase I Trial of Silymarin for Chronic Liver Diseases |
| Acronym: | SyNCH |
| Status: | Completed |
| Study Results: | No Results Available |
| Results: | -- |
| Conditions: | Hepatitis C|Non-Alcoholic Fatty Liver Disease |
| Interventions: | Drug: Placebo|Drug: Silymarin |
| Outcome Measures: | Adverse events |
| Sponsor/Collaborators: | National Center for Complementary and Integrative Health (NCCIH)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| Gender: | All |
| Age: | 18 Years and older ?? (Adult, Older Adult) |
| Phases: | Phase 1 |
| Enrollment: | 56 |
| Study Type: | Interventional |
| Study Designs: | Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science |
| Start Date: | November 2006 |
| Completion Date: | February 2008 |
| Results First Posted: | -- |
| Last Update Posted: | February 20, 2008 |
| Locations: | Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|University of Pittsburgh, Graduate School of Public Health, Pittsburgh, Pennsylvania, United States |
| URL: | https://ClinicalTrials.gov/show/NCT00389376 |
